HiGenoMB® Molecular Biology Division of HiMedia Laboratories Pvt. Ltd. the pioneers in Indian BioSciences manufacturing segment adds another feather in the cap with their newly CE/IVD approved Hi-PCR®COVID-FLU Multiplex Probe PCR Kit (MBPCR262).
Molecular Diagnostics based on real-time PCR is increasingly becoming the gold standard post COVID-19. Hi-PCR® COVID-FLU Multiplex Probe PCR Kit, is a multiplex PCR kit that can differentiate between COVID-19 and Flu using a single tube reaction. It is recommended for sensitive and specific detection of SARS-CoV-2 and Influenza virus in clinical samples. Targets include RdRp gene of SARS-CoV-2 virus, Influenza A virus (Swine flu 2009 H1N1 virus, seasonal H3N2 & seasonal H1N1), Influenza B virus and Internal control (IC).
Covid-19 pandemic has impacted millions of lives globally. The symptoms are similar to those of influenza, both being contagious respiratory illness. As the public's concern of contracting Covid-19 continued to rise, flu symptoms were frequently mistaken for those of Covid-19. Performing separate tests for detection of Covid-19 and Influenza can be time consuming, costly & a cumbersome affair. HiMedia’s MBPCR262 being a multiplex kit eliminates the need for separate tests thereby significantly reducing the time & resources.
Dr. Kavita Khadke, Director of HiMedia’s Molecular Biology Division (HiGenoMB®) says ‘’An early diagnostic tool that would help to differentiate between Flu and Covid-19 was the need of the hour. Time is of essence; this kit can give results in a short span, enabling rapid and appropriate detection that could help in early diagnosis & treatment.
Please visit their website www.himedialabs.com for more details about HiGenoMB® products related COVID Molecular testing.
This press release is published by VOH team.*
Medanta Gurugram organizes initiatives to strengthen awareness around colorectal
Metropolis' MedEngage Scholarship Program recognizes 250 medical students with S
AMRI Hospitals Kolkata set to be acquired by The Manipal Group
Dr Nitish Shetty appointed CEO of Aster DM Healthcare (India Business)
Psoriasis drug launch marks Eli Lilly’s entry into dermatology domain
SAMRIDH Healthcare invests in Critical Care Hope to catalyze tele-ICUs across th
Health Check on Wheels: Apollo Hospitals Launches Gujarat’s First Fully-equipp
Steven Mou to steer Mindray’s ‘India Mission’ as Managing Director
Making Robotics Mainstream: HCG Hospitals Collaborates with Us-Based Intuitive t
Dr. Rajeev Singh Raghuvanshi appointed Drugs Controller General of India
Accurex BGMS (Blood Glucose Monitoring System) Factory Inauguration at Andhra Pr
VOH: Incubator Driving Innovation and Improving Access to Healthcare in India
Augnito Launches Its Developer Portal To Abridge Integration Timelines
MediBuddy acquires ‘vHealth by Aetna’, the India health business of Aetna In
Ayurveda in MBBS Curriculum?View All